4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Rapport Therapeutics, Inc. (RAPP) operates in the Biotechnology industry and is headquartered in Boston, United States with about 84 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, RAPP reported $0M in revenue and ($112M) in net income.
Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.
Interactive charts & full statements → Open the RAPP valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Total Revenue | $0M | $0M | $0M |
| Operating Income (EBIT) | ($125M) | ($83M) | ($36M) |
| Net Income | ($112M) | ($78M) | ($35M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $20M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($24M) | ($38M) | ($30M) | ($30M) | ($27M) | — |
| Net Income | ($20M) | ($34M) | ($27M) | ($27M) | ($24M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $512M | $315M | $155M | $32M |
| Total Liabilities | $28M | $10M | $181M | $42M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RAPP viewer.
About TickerBase · Data methodology & sources